Pharmaceuticals Report – Tecnoquimicas Profile Essay Sample

Colombia – Pharmaceuticals & A ; Healthcare – 04 Dec 2008 Indigenous Manufacturers SWOT Analysis Strengths Tecnoquimicas is a taking domes tic pharmaceutical company in footings of s ales with a big production web of eight fabricating s ites The company has repres entative understandings with m a n y foreign houses. including Argentina’s Gador. Pharmacia. Recordati and As tellas Weaknesses Its frogmans e offering — including favored nutrients. confectionery and pers onal attention points — may cut down focal point and financess available for developing pharmaceuticals The company is vulnerable to s trengthened bioequivalence regulations and competition from foreign generics participants Opportunities Tecnoquimicas is in the mids T of implementing a 10year inves tment program Threats Tecnoquimicas repres ents over 25 foreign houses. but the US FTA may eas e direct market entry for foreign companies Entry of foreign — Es pecially As ian — low-cos T manufacturers threatens the firm’s off-patent merchandise lines Overview Tecnoquimicas was founded in Bogota in 1934.

as a household coach ines s focal point ing on repres enting national and international companies in Colombia. The company. which is one of the larges t pharmaceuticals houses by s ales in Colombia. claims to fabricate 87 % of the merchandises it markets.

In 2005. the company reported a 20 % leap in s ales to COP60bn ( US $ 246mn ) and had es timated s ales of US $ 300mn in 2006 and US $ 350mn in 2007. Tecnoquimicas has three production workss in Cali. one of which manufactures unwritten s olid Department of State age signifiers and hous Es a R & A ; D installation The Jamundi installation produces s olids and veterinary s teriles. as. good as hous ing a QC research lab and a natural stuff warehous e. The Yumbo installation industries picks and unctions for cos metics and topical merchandises. T h e company operates s nine Dis tribution Centres in Colombia. It has opened a pick and efferves cent merchandises works in Villa Rica for regional unit Tecnofar TQ. Since the 1990s. Tecnoquimicas has expanded internationally. concentrate ing on regional markets. In 1993. it acquired the MK and McK trade names from McKes s on Corporation. and began to bring forth and s ell generics in the Andean part. In July 2008. the company reportedly s igned a trade with the IFC. the World Bank’s loaning arm. to s ell 10 % of its s hares in return for US $ 25mn to fund future expans ion in Central and South America with a peculiar focal point on the Andean part.

Product Portfolio Bes ides pharmaceuticals. the company is active in the pers onal attention. infant nutrition. confectionery. hous ehold merchandises. veterinary and telecommunications s egments. Tecnoquimicas ‘ big pharmaceutical offering includes generic pres cription drugs. pers onal attention merchandises and carnal wellness merchandises. Get downing with an understanding with Bayer for Alka-Seltzer in 1941. the company now repres ents 24 companies in Colombia. including Argentina’s Gador. Italy’s Recordati and Japan’s As tellas. In 1986. Tecnoquimicas acquired Merck & A ; Co’s Colombian pharmaceuticals works. Tecnoquimicas repres ented the US drug major in the state until 1996. Tecnoquimicas is a leader in the Colombian Ho pital drugs s egment and the Immigration and Naturalization Services titutional market. T H vitamin E company’s generic anti-infectives portfolio runs to 37 merchandises. The company fields 28 cardiovas cular generics. 13 cardinal nervous s Y tem ( CNS ) drugs. 19 mus culo-s keletal merchandises. 13 alimentary/metabolis m readyings and nine RESs piratory pres entations. Contacts Tecnoquim icas C alle 23 7-39 C Ali Tel: +57 ( 2 ) 882 5555 World Wide Web. tecnoquim icas. com. co Leading Drug Merchandises Flucanazole Lipicare ( Lipitor ) Sim vastatin C rem a No. 4 Enalapril Glim epiride Fluoxetine Tecnoquimicas

Recent Activity Tecnoquimicas has announced programs to inves t s ome COP25bn ( US $ 10mn ) in 2006. chiefly on spread outing and upgrading its production installations and offices. The Jamundi installation — which produces unwritten s olid signifiers for human us e — and the Villa Rica unit will pull a major s hare of the new s pending. Senior company s ources ALSs o remark that regional expans ion will stay a precedence The company has grown its s ales in Ecuador by s ome 25 % s ince 2002. and claims to be. the market leader in footings of units s old in the state In 2007. the company s assistance it aimed to. increas e s ales at that place to US $ 20mn by year-end. The house entered Peru in early 2006. Tecnoquimicas has vigorous ly protes ted an FTA with the US. chiefly oppos ing new IP provis ions. The company markets a figure of transcripts of patented pharmaceuticals. which has brought it into struggle with R & A ; D-bas erectile dysfunction multinationals in the pas t. Nevertheles s. it has s trong potency in the field of generics. although the entry of low-cos T As ian manufacturers could intens ify competitory pres s ures in the coming old ages. This stuff is protected by international right of first publication Torahs. and us e of this is s ubject to our Footings & A ; Conditions. © 2012 Bus ines s Monitor International Ltd